86 related articles for article (PubMed ID: 1287602)
1. Use of subtherapeutical dose of cisplatin and vitamin C against murine Dalton's lymphoma.
Prasad SB; Giri A; Arjun J
Pol J Pharmacol Pharm; 1992; 44(4):383-91. PubMed ID: 1287602
[TBL] [Abstract][Full Text] [Related]
2. Chemo-immunotherapeutical studies on Dalton's lymphoma in mice using cisplatin and ascorbic acid: synergistic antitumor effect in vivo and in vitro.
Sarna S; Bhola RK
Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):327-33. PubMed ID: 8010874
[TBL] [Abstract][Full Text] [Related]
3. Sex dimorphism in antitumor response of chemotherapeutic drug cisplatin in a murine host-bearing a T-cell lymphoma.
Gupta V; Singh SM
Anticancer Drugs; 2008 Jul; 19(6):583-92. PubMed ID: 18525317
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin- and dietary ascorbic acid-mediated changes in the mitochondria of Dalton's lymphoma-bearing mice.
Martha KR; Rosangkima G; Amenla L; Rongpi T; Prasad SB
Fundam Clin Pharmacol; 2013 Jun; 27(3):329-38. PubMed ID: 22211279
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effect of cisplatin against murine ascites Dalton's lymphoma.
Prasad SB; Giri A
Indian J Exp Biol; 1994 Mar; 32(3):155-62. PubMed ID: 8070834
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of Abrus abrin-derived peptide fraction against Dalton's lymphoma ascites model.
Bhutia SK; Mallick SK; Maiti S; Maiti TK
Phytomedicine; 2009 Apr; 16(4):377-85. PubMed ID: 18706794
[TBL] [Abstract][Full Text] [Related]
7. Structural and biochemical changes in mitochondria after cisplatin treatment of Dalton's lymphoma-bearing mice.
Prasad SB; Rosangkima G; Kharbangar A
Mitochondrion; 2010 Jan; 10(1):38-45. PubMed ID: 19766736
[TBL] [Abstract][Full Text] [Related]
8. Cyclophosphamide and ascorbic acid-mediated ultrastructural and biochemical changes in Dalton's lymphoma cells in vivo.
Prasad SB; Rosangkima G; Nicol BM
Eur J Pharmacol; 2010 Oct; 645(1-3):47-54. PubMed ID: 20655303
[TBL] [Abstract][Full Text] [Related]
9. Chemoimmunotherapeutical studies on Dalton's lymphoma with cis-platin.
Bahadur A
Pol J Pharmacol Pharm; 1985; 37(4):463-8. PubMed ID: 4080643
[TBL] [Abstract][Full Text] [Related]
10. Antitumour activity of some plants from Meghalaya and Mizoram against murine ascites Dalton's lymphoma.
Rosangkima G; Prasad SB
Indian J Exp Biol; 2004 Oct; 42(10):981-8. PubMed ID: 15511001
[TBL] [Abstract][Full Text] [Related]
11. Immunopotentiation in mice bearing a spontaneous transplantable T-cell lymphoma: role of thymic extract.
Shanker A; Singh SM
Neoplasma; 2003; 50(4):272-9. PubMed ID: 12937840
[TBL] [Abstract][Full Text] [Related]
12. Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's lymphoma ascites tumor in mice.
Ajith TA; Harikumar KB; Thasna H; Sabu MC; Babitha NV
Clin Chim Acta; 2006 Apr; 366(1-2):322-8. PubMed ID: 16380106
[TBL] [Abstract][Full Text] [Related]
13. Chlorambucil and ascorbic acid-mediated anticancer activity and hematological toxicity in Dalton's ascites lymphoma-bearing mice.
Kalita S; Verma AK; Prasad SB
Indian J Exp Biol; 2014 Feb; 52(2):112-24. PubMed ID: 24597143
[TBL] [Abstract][Full Text] [Related]
14. Effect of allogenic Dalton's lymphoma cells on the activation of murine peritoneal macrophages to tumoricidal state by cisplatin and lipopolysaccharide (LPS).
Singh SM; Singh RK; Sodhi A
Neoplasma; 1992; 39(3):151-5. PubMed ID: 1528319
[TBL] [Abstract][Full Text] [Related]
15. Induction of cell mediated immunity in vitro and in vivo after cis-platin treatment.
Bahadur A; Sodhi A
Pol J Pharmacol Pharm; 1985; 37(4):453-61. PubMed ID: 4080642
[TBL] [Abstract][Full Text] [Related]
16. Effects of deoxycoformycin in mice. II. Differences between the drug sensitivities and purine metabolizing enzymes of transplantable lymphomas of varying immunologic phenotypes.
Ratech H; Kim J; Asofsky R; Thorbecke GJ; Hirschhorn R
J Immunol; 1984 Jun; 132(6):3077-84. PubMed ID: 6202772
[TBL] [Abstract][Full Text] [Related]
17. Sialic acid changes in Dalton's lymphoma-bearing mice after cyclophosphamide and cisplatin treatment.
Nicol BM; Prasad SB
Braz J Med Biol Res; 2002 May; 35(5):549-53. PubMed ID: 12011939
[TBL] [Abstract][Full Text] [Related]
18. Adoptive immunotherapy of tumor in mice in combination with cyclophosphamide.
Sarna S; Bhola RK
Arch Immunol Ther Exp (Warsz); 1989; 37(5-6):533-8. PubMed ID: 2487364
[TBL] [Abstract][Full Text] [Related]
19. Anticarcinogenic activity of Withania somnifera Dunal against Dalton's ascitic lymphoma.
Christina AJ; Joseph DG; Packialakshmi M; Kothai R; Robert SJ; Chidambaranathan N; Ramasamy M
J Ethnopharmacol; 2004 Aug; 93(2-3):359-61. PubMed ID: 15234777
[TBL] [Abstract][Full Text] [Related]
20. Toxicity and antineoplastic effect of (24R)-1,24-dihydroxyvitamin D3 (PRI-2191).
Wietrzyk J; Pełczyńska M; Madej J; Dzimira S; Kuśnierczyk H; Kutner A; Szelejewski W; Opolski A
Steroids; 2004 Sep; 69(10):629-35. PubMed ID: 15465107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
